Danaher Corporation
Danaher Authorizes New Share Repurchase Program
Summary
On September 9, 2025, Danaher Corporation's Board of Directors approved a new share repurchase program authorizing the repurchase of up to 35 million shares of the Company's common stock from time to time on the open market, in privately negotiated transactions, or by other methods at management's discretion. Additionally, the Board amended the Company's By-laws to revise advance notice and related procedural and disclosure requirements for shareholders to propose business at a meeting of shareholders. The new share repurchase program is in addition to previous authorizations and has no expiration date. Exhibits include the Amended and Restated By-Laws.
Profitelligence Alerts
Get alerts for DHR
Be first to know when Danaher Corporation files with the SEC.
Filing Categories
Advertisement
About Danaher Corporation
Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.
Official SEC Documents
Advertisement